Research Alliance Corp III (RACC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $10.16, +0.00% vs the prior close of $10.16.
- Volume 1.48K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RACC ends flat (+0.0%) to $10.16. Closed at $10.16, +0.00% vs the prior close of $10.16. Day range $10.16–$10.20, opened at $10.20.
RACC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — RACC ends flat (+0.0%) to $10.16
- Closed at $10.16, +0.00% vs the prior close of $10.16. Day range $10.16–$10.20, opened at $10.20.
- Volume was 1.48K shares, 0.0x its 50-day average of 88.26K — lighter than usual.
- Price is -35.4% vs its 50-day average ($15.72).
- 52-week range $9.62–$33.50; today's close sits at 2% of that range, 69.7% below the 52-week high.
Oct 15, 2026 — RACC ends flat (+0.1%) to $10.16
- Closed at $10.16, +0.10% vs the prior close of $10.15. Day range $10.16–$10.17, opened at $10.16.
- Volume was 4.50K shares, 0.1x its 50-day average of 88.82K — lighter than usual.
- Price is -36.5% vs its 50-day average ($16.01).
- 52-week range $9.62–$33.50; today's close sits at 2% of that range, 69.7% below the 52-week high.
Oct 14, 2026 — RACC ends flat (+0.0%) to $10.15, 4 down days in a row
- Closed at $10.15, +0.00% vs the prior close of $10.15. Day range $10.15–$10.21, opened at $10.15.
- Volume was 118.70K shares, 1.4x its 50-day average of 87.34K.
- Price is -37.7% vs its 50-day average ($16.30).
- 52-week range $9.62–$33.50; today's close sits at 2% of that range, 69.7% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — RACC ends flat (-0.3%) to $10.15, 3 down days in a row
- Closed at $10.15, -0.29% vs the prior close of $10.18. Day range $10.13–$10.23, opened at $10.13.
- Volume was 50.00K shares, 0.6x its 50-day average of 86.43K — lighter than usual.
- Price is -38.8% vs its 50-day average ($16.59).
- 52-week range $9.62–$33.50; today's close sits at 2% of that range, 69.7% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — RACC ends flat (+0.0%) to $10.18
- Closed at $10.18, +0.00% vs the prior close of $10.18. Day range $10.11–$10.21, opened at $10.21.
- Volume was 20.10K shares, 0.2x its 50-day average of 86.65K — lighter than usual.
- Price is -39.5% vs its 50-day average ($16.83).
- 52-week range $9.62–$33.50; today's close sits at 2% of that range, 69.6% below the 52-week high.
Oct 9, 2026 — RACC dips 1.2% to $10.18
- Closed at $10.18, -1.17% vs the prior close of $10.30. Day range $10.18–$10.34, opened at $10.34.
- Volume was 34.10K shares, 0.4x its 50-day average of 86.55K — lighter than usual.
- Price is -40.3% vs its 50-day average ($17.06).
- 52-week range $9.62–$33.50; today's close sits at 2% of that range, 69.6% below the 52-week high.
Oct 8, 2026 — RACC rises 1.5% to $10.30
- Closed at $10.30, +1.48% vs the prior close of $10.15. Day range $10.19–$10.30, opened at $10.20.
- Volume was 118.60K shares, 1.2x its 50-day average of 95.56K.
- Price is -40.5% vs its 50-day average ($17.30).
- 52-week range $9.62–$33.50; today's close sits at 3% of that range, 69.3% below the 52-week high.
Oct 7, 2026 — RACC dips 1.5% to $10.15, a 3-month low, 6 down days in a row
- Closed at $10.15, -1.46% vs the prior close of $10.30. Day range $10.15–$10.31, opened at $10.31.
- Volume was 109.60K shares, 1.1x its 50-day average of 95.71K.
- Price is -41.7% vs its 50-day average ($17.42).
- 52-week range $9.62–$33.50; today's close sits at 2% of that range, 69.7% below the 52-week high.
- That makes 6 straight losses.
Oct 6, 2026 — RACC dips 0.7% to $10.30, a 3-month low, 5 down days in a row
- Closed at $10.30, -0.68% vs the prior close of $10.37. Day range $10.30–$10.45, opened at $10.45.
- Volume was 39.30K shares, 0.4x its 50-day average of 100.55K — lighter than usual.
- Price is -41.1% vs its 50-day average ($17.49).
- 52-week range $9.62–$33.50; today's close sits at 3% of that range, 69.3% below the 52-week high.
- That makes 5 straight losses.
Oct 5, 2026 — RACC slides 3.3% to $10.37, a 3-month low, 4 down days in a row
- Closed at $10.37, -3.26% vs the prior close of $10.72. Day range $10.34–$10.54, opened at $10.50.
- Volume was 36.00K shares, 0.4x its 50-day average of 99.83K — lighter than usual.
- Price is -40.9% vs its 50-day average ($17.55).
- 52-week range $9.62–$33.50; today's close sits at 3% of that range, 69.0% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — RACC dips 1.0% to $10.72, 3 down days in a row
- Closed at $10.72, -1.02% vs the prior close of $10.83. Day range $10.55–$10.72, opened at $10.71.
- Volume was 5.20K shares, 0.1x its 50-day average of 99.76K — lighter than usual.
- Price is -39.0% vs its 50-day average ($17.57).
- 52-week range $9.62–$33.50; today's close sits at 5% of that range, 68.0% below the 52-week high.
- That makes 3 straight losses.
RACC latest news & SEC filings
Every SEC filing by or about RACC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 11, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $54.05K
Aug 3, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 28, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade RACC
- How much it moves: over the last 20 sessions the average daily move was 0.80% (largest 3.3%). That is a relatively calm stock.
- Liquidity: about 33.39K shares (≈$339.28K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.16 vs a range of $9.62–$33.50 (2% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 12, 2026; 8-K Jul 27, 2026; 10-Q Jul 2, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
RACC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 10.20 | 10.20 | 10.16 | 10.16 | 1.48K |
| Oct 15, 2026 | 10.16 | 10.17 | 10.16 | 10.16 | 4.50K |
| Oct 14, 2026 | 10.15 | 10.21 | 10.15 | 10.15 | 118.70K |
| Oct 13, 2026 | 10.13 | 10.23 | 10.13 | 10.15 | 50.00K |
| Oct 12, 2026 | 10.21 | 10.21 | 10.11 | 10.18 | 20.10K |
| Oct 9, 2026 | 10.34 | 10.34 | 10.18 | 10.18 | 34.10K |
| Oct 8, 2026 | 10.20 | 10.30 | 10.19 | 10.30 | 118.60K |
| Oct 7, 2026 | 10.31 | 10.31 | 10.15 | 10.15 | 109.60K |
| Oct 6, 2026 | 10.45 | 10.45 | 10.30 | 10.30 | 39.30K |
| Oct 5, 2026 | 10.50 | 10.54 | 10.34 | 10.37 | 36.00K |
| Oct 2, 2026 | 10.71 | 10.72 | 10.55 | 10.72 | 5.20K |
| Oct 1, 2026 | 10.83 | 10.83 | 10.83 | 10.83 | 0 |
| Sep 30, 2026 | 10.80 | 10.91 | 10.50 | 10.83 | 62.50K |
| Sep 29, 2026 | 10.31 | 10.90 | 10.31 | 10.88 | 13.10K |
| Sep 28, 2026 | 10.95 | 10.95 | 9.62 | 10.71 | 50.80K |
| Sep 25, 2026 | 10.95 | 10.96 | 10.92 | 10.92 | 2.70K |
| Sep 24, 2026 | 11.06 | 11.06 | 11.06 | 11.06 | 0 |
| Sep 23, 2026 | 11.06 | 11.06 | 11.06 | 11.06 | 0 |
| Sep 22, 2026 | 11.06 | 11.06 | 11.06 | 11.06 | 300 |
| Sep 21, 2026 | 10.94 | 11.10 | 10.94 | 11.10 | 900 |
About Research Alliance Corp III
Research Alliance Corp III (RACC) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NEW YORK, NY. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 2118032.
RACC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Matthew Hammond | Chief Executive Officer | May 21, 2026 |
| Michael F Maclean | Director | May 19, 2026 |
| Timothy J Miller | Director | May 19, 2026 |
| Alliance Holdings Iii Llc /Cayman Research | Director | May 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Francis Sherman Adams | Chief Financial Officer | May 19, 2026 |
| Matthew Hammond | Chief Executive Officer | May 21, 2026 |
| Henry William Stusnick | COO and CBO | May 19, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
RACC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $76.31M, total liabilities $2.31M, cash $— (as of Jun 30, 2026).
RACC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on RACC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.